Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
included in hemorrhagic fevers |
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(Rubeola), all presentations |
Until 4 days after onset of rash; duration of illness in immune compromised |
Immediately contact HEIP. Susceptible heatlhcare personnel (HCP) should not enter room if immune HCP are available, regardless of presumptive evidence of immunity. HCP should use respiratory protection that is at least as protective as a fit-tested N95 respirator upon entry into the care area. Additional resources, including for testing, are available on the measles web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
(Burkholderia (Pseudomonas) pseudomallei) |
Notify the Microbiology laboratory when submitting specimens for culture from patients known or suspected to have this disease (353-1268) |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Listeria monocytogenes | |||
Neisseria meningitidis (known or suspected) |
Until 24 hrs after initiation of effective therapy |
||
Pneumococcal (Streptococcus pneumoniae) | |||
Tuberculosis*** |
***Patient should be examined for evidence of current (active) pulmonary tuberculosis. If evidence exists, see Tuberculosis below for additional isolations. |
||
Other diagnosed bacterial | |||
Varicella, disseminated (e.g., meningitis + rash) | |||
Unknown etiology |
Until etiology is determined or Neisseria meningitidis is ruled out |
||
Aseptic (non-bacterial or viral [except varicella zoster*] meningitis; also see enterovirus) | |||
Bacterial, gram negative enteric, in neonates | |||
Fungal** |
**Alert the Microbiology Laboratory (353-1268) prior to submitting specimens for culture from patients with suspected or confirmed Coccidiodes meningitis |
||
Haemophilus influenzae (known or suspected) |
Until 24 hrs after initiation of effective therapy |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Adult and Pediatric hematology/oncology/BMT patients: All other patients: Duration of illness |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Please continue isolation until the case is discussed with Infection Prevention. Isolation will be needed until lesions have crusted, those crusts have separated, and a fresh layer of healthy skin has formed underneath. |
Immediately contact HEIP. Refer to the UCSF Mpox Tip Sheet. Additional resources, including for testing, are available on the Mpox web page. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Enterococcus, vancomycin resistant (VRE) |
If drainage cannot be contained by dressing, add Contact + Standard Isolation |
||
Enteric Gram negative organisms: Acinetobacter spp. (CP-gene positive), Pseudomonas aeruginosa (CP-gene positive or cefepime or ceftazidime resistant), carbapenem resistant Enterobacteriaciae CRE (see CRE section) |
Duration of hospitalization and upon readmission. |
Discontinuation will be determined by Infection Prevention on a case by case basis. If at least 6 months have passed since last positive culture, the patient may qualify for removal of the MDRO flag. Please contact the Infection Prevention Department to discuss.
|
|
Staphylococcus aureus, nafcillin / methicillin resistant | |||
Staphylococcus aureus, vancomycin intermediate/resistant |
Duration of hospitalization and upon readmission. |
Discontinuation will be determined by Infection Prevention on a case by case basis. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 5 days after the onset of swelling |
Susceptible HCWs should not provide care if immune caregivers are available. HCWs should use masks regardless of immune status. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Non-tuberculous mycobacteria (atypical), pulmonary or wound |